AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 161 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 1.31 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $621,000 | -11.5% | 10,635 | -20.0% | 0.04% | -15.7% |
| Q3 2016 | $702,000 | -77.9% | 13,290 | -53.5% | 0.05% | -71.2% |
| Q2 2015 | $3,176,000 | +9.7% | 28,580 | -6.9% | 0.18% | 0.0% |
| Q1 2015 | $2,895,000 | -33.8% | 30,700 | -21.3% | 0.18% | -30.3% |
| Q4 2014 | $4,372,000 | +1444.9% | 39,020 | +744.6% | 0.25% | +1593.3% |
| Q3 2014 | $283,000 | – | 4,620 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 2,719,998 | $155,502,000 | 4.38% |
| Casdin Capital, LLC | 295,000 | $16,865,000 | 4.11% |
| Opaleye Management Inc. | 130,000 | $7,432,000 | 2.38% |
| Opus Point Partners Management, LLC | 28,704 | $1,641,000 | 1.42% |
| Fernwood Investment Management, LLC | 27,550 | $1,575,000 | 0.84% |
| Rhenman & Partners Asset Management AB | 100,000 | $5,717,000 | 0.77% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 760,116 | $43,456,000 | 0.65% |
| Eventide Asset Management | 214,000 | $12,234,000 | 0.64% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 262,984 | $15,035,000 | 0.59% |
| CAPITAL GUARDIAN TRUST CO | 663,089 | $37,909,000 | 0.54% |